Epidemiology, Diagnosis, and Control of Monkeypox Disease: A comprehensive Review

Mahendra Pal¹, Fisseha Mengstie¹ and Venkataramana Kandi^2,

¹College of Veterinary Medicine, Addis Ababa University, Debre Zeit, Ethiopia

²Prathima Institute of Medical Sciences, Karimnagar, Telengana, India

Cite this paper:
Mahendra Pal, Fisseha Mengstie and Venkataramana Kandi. Epidemiology, Diagnosis, and Control of Monkeypox Disease: A comprehensive Review. American Journal of Infectious Diseases and Microbiology. 2017; 5(2):94-99. doi: 10.12691/ajidm-5-2-4

Abstract

Human monkeypox is an emerging viral zoonotic disease, which is caused by monkey pox virus. The disease occurs mostly in the rain forests of central and western Africa. People living in or near the forested areas may have indirect or low-level exposure, possibly leading to subclinical infection. However, the disease recently emerged in the United States in imported wild rodents from Africa. Monkeypox has a clinical presentation like ordinary forms of smallpox, including flulike symptoms, fever, malaise, back pain, headache, and characteristic rash. In view of the eradication of smallpox, such symptoms in a monkepox endemic region should be carefully diagnosed. Primarily, monkey pox transmission to humans is believed to occur through direct contact with infected animals or possibly by ingestion of inadequately cooked flesh. Infection by inoculation through contact with cutaneous or mucosal lesions on the animal, especially when the skin barrier is compromised secondary to bites, scratches, or other trauma is a possibility. Laboratory diagnosis is imperative because it is clinically indistinguishable from other pox-like illnesses. There are no licensed therapies to treat human monkey pox viral infection; however, the smallpox vaccine can protect against the disease. The discontinuation of general vaccination in the 1980s has given rise to increasing susceptibility to monkey pox virus infection in the human population. This has led to fears that monkey pox virus could be used as a bioterrorism agent. Effective prevention relies on limiting the contact with infected patients or animals and limiting the respiratory exposure to infected patients.

Keywords:
monkeypox public health virus zoonosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Marennikova SS, Šeluhina EM, Mal’ceva NN, Ladnyj ID. 1972. Poxviruses isolated from clinically ill and asymptomatically infected monkeys and a chimpanzee. Bulletin of the World Health Organ.46:613-620.
[2]	Arita I, Jezek Z, Khodakevich L, and Ruti K. 1985. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg. 34: 781-789.
[3]	Pal M.2007. Zoonoses.2nd Ed. Satyam Publishers, Jaipur, India.
[4]	Landyi, ID., Ziegler, P and Kima, A. 1972. A human infectioun caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo (DRC). Bull World Health Organ. 46: 593-597.
[5]	Jezek Z, Khodakevich LN, and Szczeniowski MV.1988. Human monkey pox: its clinico-epidemiological characteristics. Zh Mikrobiol Epidemiol Immunobiol. 6:23-30.
[6]	Hutin, YJ., Williams, RJ., Malfait, P., Pebody, R., Loparev, VN and Ropp, SL. 2001. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 7: 434-438.
[7]	Von Magnus, P., Andersen, EK., Petersen, KB and Birch-Andersen, AA. 1959. A pox-like disease in cynomolgus monkeys. Acta Pathol. Microbiol. Immunol. Scand.46, 156-176.
[8]	Jezek, Z and Fenner, F. 1988. Human monkeypox. Monographs in Virology, Vol. 17. Karger, Basel.P. 140
[9]	Reed, KD., Melski, JW., Graham, MB., Regnery, RL., Sotir, MJ., Wegner, MV., et al. 2004. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 350:342-350.
[10]	Likos, AM., Sammons, SA., Olson, VA., Frace, AM and Olsen-Rasmussen, 2005. A tale of two clades: monkeypox viruses. J Gen Virol. 86: 2661-2672.
[11]	Hutson, CL., Carroll, DS and Self, J. 2010. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology 402: 72-82.
[12]	Fields, BN., Knipe, DM., Howley, PM., Chanock, RM., Melnick, JL., Monath, TP., Roizman, B and Straus, SE. 1995. Fields Virology, 3rd Ed. Lippincott, Williams and Wilkins, Philadelphia, USA.
[13]	Esposito, JJ and Knight, JC. 1985. Orthopox virus DNA: a comparison of restriction profiles and maps. Virology 143: 230-251.
[14]	Gispen R, and Brand-Saathof B. 1974. Three specific antigens produced in vaccinia, variola, and monkeypox infections. J Infect Dis. 129: 289-95.
[15]	Pattyn SR. 2000. Monkeypoxvirus infections. Rev Sci Tech. 19: 92-97.
[16]	Morand A, Delaigue S, and Morand JJ. 2017. Review of poxvirus: emergence of monkeypox. Med Sante Trop. 27: 29-39.
[17]	Reynolds, MG., Carroll, DS and Olson, VA. 2010. A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. Am J Trop Med Hyg. 82:746-54.
[18]	Reynolds, MG and Damon, IK. 2012. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 20:80-87.
[19]	Centers for Disease Control and Prevention .2003. Update: multistate outbreak of monkeypox – Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin. Morb Mortal Wkly Rep 52: 642-646.
[20]	Huhn, GD., Bauer, AM., Yorita, K., Graham, MB., Sejvar, J and Likos, A. 2005.
[21]	Jezek, Z, Szczeniowski, M., Paluku, KM and Mutombo, M. 1987. Human monkeypox: clinical features of 282 patients. J Infect Dis.156 : 293-298.
[22]	Breman, JG., Kalisa, R., Steniowski, MV., Zanotto, E., Gromyko, AI and Arita, L. 1980. Human monkeypox 1970-74. Bull. WHO 58:165-182.
[23]	Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis.41:1742-1751.
[24]	Khodakevich, L., Jezek, Z and Kinzanzka, K. 1986. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet. 1(8472):98-9.
[25]	Di Giulio DB, and Eckburg PB.2004. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004 Jan;4 (1):15-25.
[26]	Meyer, H., Perrichot, M and Stemmler, M. 2002. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. Clin Microbiol; 40: 2919-2921.
[27]	Sejvar, JJ., Chowdary,Y., Schomogyi, M., Stevens, J., Patel, J and Karem, K. 2004. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis. 190: 1833-1840.
[28]	Monkeypox. http://misc.medscape.com/pi/iphone/medscapeapp/html/A1134714-business.html Accessed: March 20, 2017.
[29]	Karem, KL., Reynolds, M., Braden, Z., Lou, G., Bernard, N and Patton, J. 2005. Characterizationof acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol.12: 867-872.
[30]	Reynolds, MG., Yorita, KL., Kuehnert, MJ., Davidson, WB., Huhn, GD and Holman, R. 2006. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 194: 773-780.
[31]	Cono, J., Casey, CG and Bell, DM. 2003. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recommend. Rep. 52: 1-28.
[32]	Quiner CA, Moses C, Monroe BP, et al. Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo. Yang Y, ed. PLoS ONE. 2017; 12(2): e0168664.
[33]	Realegeno S, Puschnik AS, Kumar A, Goldsmith C et al.2017. Monkeypox virus host factor screen in haploid cells identifies essential role of GARP complex in extracellular virus formation. J Virol. Mar 22. pii: JVI.00011-17.
[34]	Iizuka I, Ami Y, Suzaki Y, Nagata N et al.2016 A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox. Jpn. J. Infect. Dis. 2016.
[35]	Maksyutov RA, Gavrilova EV, and Shchelkunov SN. 2016. Species-specific differentiation of variola, monkeypox, and varicella-zoster viruses by multiplex real-time PCR assay. J Virol Methods. 236: 215-20.
[36]	Li D, Wilkins K, McCollum AM, et al.2017. Evaluation of the GeneXpert for Human Monkeypox Diagnosis. The American Journal of Tropical Medicine and Hygiene 96: 405-410.
[37]	Stern D, Olson VA, Smith SK, et al.2016. Rapid and sensitive point-of-care detection of Orthopoxviruses by ABICAP immunofiltration. Virology Journal13: 207.
[38]	Stern D, Pauly D, Zydek M, et al.2016. Development of a genus-specific antigen capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening. Wang Y, ed. PLoS ONE. 11(3):e0150110.